131949-86-5

Upstream product

• 2389-45-9 Boc-Lys(Z)-OH 
• 126090-32-2 N-methyl-N-(phenylmethyl)-L-phenylalaninamide hydrochloride 

Downstream Products

• 131949-30-9 (1H-indol-3-ylcarbonyl)-Lys(Boc-Thr)-Phe-NMeBzl 
• 131949-24-1 (1H-indol-3-ylcarbonyl)-Lys(Z)-Phe-NMeBzl 
• 150113-41-0 (1H-indol-3-ylcarbonyl)-Lys(Boc-Gln)-Phe-NMeBzl 
• 150113-42-1 (1H-indol-3-ylcarbonyl)-Lys(Boc-Ser)-Phe-NMeBzl 
• 150113-44-3 Boc-Lys(Z-Thr)-Phe-NMeBzl 
• 150113-40-9 (1H-indol-2-ylcarbonyl)-Lys(Boc-Thr)-Phe-NMeBzl 
• 131949-31-0 (1H-indol-3-ylcarbonyl)-Lys(Boc-β-Ala)-Phe-NMeBzl 
• 131949-32-1 (1H-indol-3-ylcarbonyl)-Lys(Boc-Gly)-Phe-NMeBzl 
• 150113-16-9 (1H-indol-2-ylcarbonyl)-Lys(Z)-Phe-NMeBzl 

Relevant academic research and scientific papers

Studies on Neurokinin Antagonists. 3. Design and Structure-Activity Relationships of New Branched Tripeptides Nα-(Substituted L-aspartyl, L-ornithyl, or L-lysyl)-N-methyl-N-(phenylmethyl)-L-phenylalaninamides as Substance P Antagonists

As an extension of our study on discovering a novel substance P (SP) antagonist, we designed new branched tripeptides containing L-aspartic acid, (2 and 5), L-ornithine (3 and 6), and L-lysine (4 and 7) by reconstructing the structure of the previously re